Related Experiment Video
Updated: Nov 2, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.1K
Blood Count-derived Immunoinflammatory Markers in Thyroidassociated Ophthalmopathy
Volkan Yeter1, Nurullah Koçak1, Mehmet Tayfun Arslan2
1Department of Ophthalmology, Ondokuz Mayıs University, Samsun, Turkey.
Korean Journal of Ophthalmology : KJO
|June 13, 2021
Summary
Systemic immune-inflammatory markers like neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammatory index (SII) may help identify thyroid-associated ophthalmopathy (TAO). Lower initial platelet counts in TAO patients may predict the need for systemic therapy.
Area of Science:
- Ophthalmology
- Immunology
- Hematology
Background:
- Thyroid-associated ophthalmopathy (TAO) is an autoimmune condition affecting the eyes.
- Systemic immunoinflammatory parameters derived from blood counts are increasingly recognized for their role in various diseases.
Purpose of the Study:
- To evaluate the diagnostic and prognostic value of blood-count derived systemic immunoinflammatory parameters in patients with TAO.
Main Methods:
- A retrospective case-control study involving 46 TAO patients and 46 controls.
- Analysis of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio, and systemic immune-inflammatory index (SII).
- Assessment of associations between these parameters and clinical outcomes in TAO patients.
Main Results:
- Significant differences in NLR, PLR, SII, and lymphocyte count were observed between TAO patients and controls (p < 0.05).
- These inflammatory parameters showed no significant prognostic effect on TAO clinical outcomes.
- Lower initial platelet count and PLR were associated with the need for systemic treatment in TAO patients during follow-up (p = 0.001 and p = 0.02, respectively).
- Initial platelet count was significantly linked to subsequent steroid requirement (β = -0.02, p = 0.03).
Conclusions:
- NLR, PLR, and SII may serve as potential diagnostic markers for TAO.
- These markers lack significant prognostic value for TAO outcomes.
- A lower initial platelet count in TAO patients might indicate a higher likelihood of requiring systemic therapy.

